Completed PHASE3 INTERVENTIONAL 2-arm NCT05620641

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

Comparative Clinical Study Among Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

Sponsor: Tanta University

Conditions Morbid Obesity Post Operative Nausea and Vomiting Sleeve Gastrectomy

Interventions Gabapentin Ondansetron 8mg

Updated 6 times since 2022 Last updated: Apr 16, 2025 Started: Oct 1, 2022 Primary completion: Feb 28, 2025 Completion: Apr 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Morbid Obesity and Post Operative Nausea and Vomiting and is currently completed. Tanta University leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

May 2025 — Present [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Dec 2024 — May 2025 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Dec 2022 — Dec 2023 [monthly]

Recruiting PHASE3

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tanta University

Data source: Tanta University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tanta, Egypt